P-CREB expression in human gliomas: Potential use in the differential diagnosis between astrocytoma and oligodendroglioma

Human Pathology

Volumn 46, Issue 2, 2015, Pages 231-238

  Barresi, Valeria ^a   Mondello, Stefania ^b   Branca, Giovanni ^a   Rajan, Thangavelu Soundara ^b   Vitarelli, Enrica ^a   Tuccari, Giovanni ^a  

^a AOU Polyclinic G Martino   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

1p 19q codeletion; Astrocytoma; Oligodendroglioma; p CREB; p53

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; KI 67 ANTIGEN; PROTEIN P53; CREB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; BRAIN NEOPLASMS; CHROMOSOME 19; GENETICS; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; PROCEDURES; YOUNG ADULT;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 19; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGODENDROGLIOMA; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84920928048     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.10.011     Document Type: Article

References (34)

1. M.R. Montminy, and L.M. Bilezikjian Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene Nature 328 1987 175 178
2. B.E. Lonze, and D.D. Ginty Function and regulation of CREB family transcription factors in the nervous system Neuron 35 2002 605 623
3. A.M. Ionescu, E.M. Schwarz, and C. Vinson PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling J Biol Chem 276 2001 11639 11647
4. D.B. Shankar, and K.M. Sakamoto The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias Leuk Lymphoma 45 2004 265 270
5. M.D. Conkright, and M. Montminy CREB: the unindicted cancer conspirator Trends Cell Biol 15 2005 457 459
6. D. Wu, H.E. Zhau, and W.C. Huang cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis Oncogene 26 2007 5070 5077
7. H.S. Seo, D.D. Liu, and B.N. Bekele Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer Cancer Res 68 2008 6065 6073
8. R. Abramovitch, E. Tavor, and J. Jacob-Hirsch A pivotal role of cyclic AMP responsive element binding protein in tumor progression Cancer Res 64 2004 1338 1346
9. K. Kinjo, S. Sandoval, K.M. Sakamoto, and D.B. Shankar The role of CREB as a proto-oncogene in hematopoiesis Cell Cycle 4 2005 1134 1135
10. R. Malla, S. Gopinath, and K. Alapati Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas PLoS One 5 2010 e13731
11. M. Golan, G. Schreiber, and S. Avissar Antidepressants elevate GDNF expression and release from C6 glioma cells in a beta-arrestin1- dependent, CREB interactive pathway Int J Neuropsychopharmacol 14 2011 1289 1300
12. T. Mantamadiotis, N. Papalexis, and S. Dworkin CREB signalling in neural stem/progenitor cells: recent developments and the implications for brain tumour biology Bioessays 34 2012 293 300
13. X. Tan, S. Wang, and L. Zhu cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a Proc Natl Acad Sci U S A 109 2012 15805 15810
14. C. Perry, E.H. Sklan, and H. Soreq CREB regulates AChE-R-induced proliferation of human glioblastoma cells Neoplasia 6 2004 279 286
15. M. Uhlen, P. Oksvold, and L. Fagerberg Towards a knowledge-based human protein atlas Nat Biotechnol 28 2010 1248 1250
16. X. Xiao, B.X. Li, B. Mitton, A. Ikeda, and K.M. Sakamoto Targeting CREB for cancer therapy: friend or foe Curr Cancer Drug Targets 10 2010 384 391
17. D.N. Louis, H. Ohgaki, O.D. Wiestler, and W.K. Cavenee WHO classification of tumours of the central nervous system 2007 IARC Press Lyon
18. Y.H. Kim, S. Nobusawa, and M. Mittelbronn Molecular classification of low-grade diffuse gliomas Am J Pathol 177 2010 2708 2714
19. C. Hartmann, B. Hentschel, and M. Tatagiba Molecular markers in low-grade gliomas: predictive or prognostic? Clin Cancer Res 17 2011 4588 4599
20. B.J. Theeler, W.K. Yung, G.N. Fuller, D.E. Groot, and JF. Moving toward molecular classification of diffuse gliomas in adults Neurology 79 2012 1917 1926
21. V. Barresi, F.R. Buttarelli, E.E. Vitarelli, A. Arcella, M. Antonelli, and F. Giangaspero Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status Hum Pathol 40 2009 1738 1746
22. F.S. Afshari, A.K. Chu, and C. Sato-Bigbee Recovery of adult oligodendrocytes is preceded by a "lag period" accompanied by upregulation of transcription factors expressed in developing young cells J Neurosci Res 67 2002 174 184
23. K. Azim, and A.M. Butt GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo Glia 59 2011 540 553
24. H. Shiga, H. Asou, and E. Ito Advancement of differentiation of oligodendrocyteprogenitor cells by a cascade including protein kinase A and cyclic AMP-response element binding protein Neurosci Res 53 2005 436 441
25. P.M. Paez, C.I. García, and J.M. Pasquini Expression of myelin basic protein in two oligodendroglial cell lines is modulated by apotransferrin through different transcription factors J Neurosci Res 83 2006 606 618
26. M.A. Hebert, and J.P. O'Callaghan Protein phosphorylation cascades associated with methamphetamine-induced glial activation Ann N Y Acad Sci 914 2000 238 262
27. H. Jiang, S.S. Chen, and J. Yang CREB-binding protein silencing inhibits thrombin-induced endothelial progenitor cells angiogenesis Mol Biol Rep 39 2012 2773 2779
28. A. Shimizu, H. Nakayama, and P. Wang Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein J Biol Chem 288 2013 2210 2222
29. L.D. Mayo, K.M. Kessler, R. Pincheira, R.S. Warren, and D.B. Donner Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase J Biol Chem 276 2001 25184 25189
30. C.E. Fuller, R.E. Schmidt, and K.A. Roth Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features J Neuropathol Exp Neurol 62 2003 1118 1128
31. Y. Okamoto, P.L. Di Patre, and C. Burkhard Population-based study on incidence, survival rates, and genetic alterations of low-grade astrocytomas and oligodendrogliomas Acta Neuropathol 108 2004 49 56
32. G. Marucci, E. Di Oto, A. Farnedi, R. Panzacchi, C. Ligorio, and M.P. Foschini Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion Hum Pathol 43 2012 374 380
33. Y. Jiao, P.J. Killela, and Z.J. Reitman Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas Oncotarget 3 2012 709 722
34. X.Y. Liu, N. Gerges, and A. Korshunov Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations Acta Neuropathol 124 2012 615 625